Sensata Technologies Holding (ST) 10-Q 29 Apr 20 2020 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2020	Apr. 15, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	001-34652
Entity Registrant Name	SENSATA TECHNOLOGIES HOLDING PLC
Entity Central Index Key	0001477294
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Incorporation, State or Country Code	X0
Entity Tax Identification Number	98-1386780
Entity Address, Address Line One	529 Pleasant Street
Entity Address, City or Town	Attleboro
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02703
Entity Address, Country	US
City Area Code	+1 (508)
Local Phone Number	236 3800
Title of 12(b) Security	Ordinary Shares - nominal value €0.01 per share
Trading Symbol	ST
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		157,161,723

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 802,971	$ 774,119
Accounts receivable, net of allowances of $15,832 and $15,129 as of March 31, 2020 and December 31, 2019, respectively	536,416	557,874
Inventories	514,274	506,678
Prepaid expenses and other current assets	115,887	126,981
Total current assets	1,969,548	1,965,652
Property, plant and equipment, net	824,553	830,998
Goodwill	3,093,598	3,093,598
Other intangible assets, net of accumulated amortization of $2,072,227 and $2,039,436 as of March 31, 2020 and December 31, 2019, respectively	738,244	770,904
Deferred income tax assets	27,293	21,150
Other assets	159,582	152,217
Total assets	6,812,818	6,834,519
Current liabilities:
Current portion of long-term debt, finance lease and other financing obligations	7,095	6,918
Accounts payable	345,787	376,968
Income taxes payable	19,390	35,234
Accrued expenses and other current liabilities	248,789	215,626
Total current liabilities	621,061	634,746
Deferred income tax liabilities	247,960	251,033
Pension and other post-retirement benefit obligations	33,716	36,100
Finance lease and other financing obligations, less current portion	28,280	28,810
Long-term debt, net	3,220,359	3,219,885
Other long-term liabilities	123,645	90,190
Total liabilities	4,275,021	4,260,764
Commitments and contingencies (Note 12)
Shareholders’ equity:
Ordinary shares, €0.01 nominal value per share, 177,069 shares authorized, and 172,596 and 172,561 shares issued, as of March 31, 2020 and December 31, 2019, respectively	2,212	2,212
Treasury shares, at cost, 15,631 and 14,733 shares as of March 31, 2020 and December 31, 2019, respectively	(784,596)	(749,421)
Additional paid-in capital	1,731,884	1,725,091
Retained earnings	1,624,773	1,616,357
Accumulated other comprehensive loss	(36,476)	(20,484)
Total shareholders’ equity	2,537,797	2,573,755
Total liabilities and shareholders’ equity	$ 6,812,818	$ 6,834,519

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) $ in Thousands	Mar. 31, 2020€ / shares	Mar. 31, 2020USD ($)shares	Dec. 31, 2019€ / shares	Dec. 31, 2019USD ($)shares
Current assets:
Accounts receivable, allowances | $		$ 15,832		$ 15,129
Accumulated amortization | $		$ 2,072,227		$ 2,039,436
Shareholders’ equity:
Ordinary shares, nominal value per share (in euros per share) | € / shares	€ 0.01		€ 0.01
Common stock, shares authorized (in shares)		177,069,000		177,069,000
Common stock, shares, issued (in shares)		172,596,000		172,561,000
Treasury stock, shares (in shares)		15,631,000		14,733,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net revenue	$ 774,269	$ 870,499
Operating costs and expenses:
Cost of revenue	566,406	580,806
Research and development	34,453	35,096
Selling, general and administrative	77,221	70,549
Amortization of intangible assets	33,092	36,143
Restructuring and other charges, net	4,498	5,309
Total operating costs and expenses	715,670	727,903
Operating income	58,599	142,596
Interest expense, net	(39,403)	(39,253)
Other, net	(12,281)	3,189
Income before taxes	6,915	106,532
(Benefit from)/provision for income taxes	(1,516)	21,467
Net income	$ 8,431	$ 85,065
Basic net income per share (in dollars per share)	$ 0.05	$ 0.52
Diluted net income per share (in dollars per share)	$ 0.05	$ 0.52

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive (Loss)/Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]
Net income	$ 8,431	$ 85,065
Other comprehensive (loss)/income, net of tax:
Cash flow hedges	(19,334)	10,060
Defined benefit and retiree healthcare plans	3,342	83
Other comprehensive (loss)/income	(15,992)	10,143
Comprehensive (loss)/income	$ (7,561)	$ 95,208

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 8,431	$ 85,065
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	34,679	27,208
Amortization of debt issuance costs	1,631	1,836
Share-based compensation	6,084	5,940
Amortization of intangible assets	33,092	36,143
Deferred income taxes	(4,100)	5,113
Loss on litigation judgment	29,200	0
Unrealized loss on derivative instruments and other	11,040	6,204
Changes in operating assets and liabilities, net of the effects of acquisitions:
Accounts receivable, net	21,458	(51,237)
Inventories	(7,596)	8,183
Prepaid expenses and other current assets	5,625	3,028
Accounts payable and accrued expenses	(19,962)	(14,917)
Income taxes payable	(15,844)	(781)
Other	(5,194)	908
Net cash provided by operating activities	98,544	112,693
Cash flows from investing activities:
Acquisitions, net of cash received	0	(1,681)
Additions to property, plant and equipment and capitalized software	(29,547)	(41,690)
Other	(3,289)	1,000
Net cash used in investing activities	(32,836)	(42,371)
Cash flows from financing activities:
Proceeds from exercise of stock options and issuance of ordinary shares	709	5,813
Payment of employee restricted stock tax withholdings	(15)	(275)
Payments on debt	(2,375)	(4,157)
Payments to repurchase ordinary shares	(35,175)	(150,749)
Payments of debt and equity issuance costs	0	(1,269)
Net cash used in financing activities	(36,856)	(150,637)
Net change in cash and cash equivalents	28,852	(80,315)
Cash and cash equivalents, beginning of period		729,833
Cash and cash equivalents, end of period	$ 802,971	$ 649,518

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Ordinary Shares	Treasury Shares	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2018		171,719	(7,571)
Beginning Balance at Dec. 31, 2018	$ 2,608,434	$ 2,203	$ (399,417)	$ 1,691,190	$ 1,340,636	$ (26,178)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding (in shares)			(6)
Surrender of shares for tax withholding	(275)		$ (275)
Stock options exercised (in shares)		248
Stock options exercised	5,813	$ 3		5,810
Vesting of restricted securities (in shares)		26
Vesting of restricted securities	0
Repurchase of ordinary shares (in shares)			(3,036)
Repurchase of ordinary shares	(150,749)		$ (150,749)
Retirement of ordinary shares (in shares)		(6)	6
Retirement of ordinary shares	0		$ 275		(275)
Share-based compensation	5,940			5,940
Net income	85,065				85,065
Other comprehensive income (loss)	10,143					10,143
Ending Balance at Mar. 31, 2019	2,564,371	$ 2,206	$ (550,166)	1,702,940	1,425,426	(16,035)
Ending Balance (in shares) at Mar. 31, 2019		171,987	(10,607)
Beginning Balance (in shares) at Dec. 31, 2019		172,561	(14,733)
Beginning Balance at Dec. 31, 2019	2,573,755	$ 2,212	$ (749,421)	1,725,091	1,616,357	(20,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Surrender of shares for tax withholding	(15)		$ (15)
Stock options exercised (in shares)		34
Stock options exercised	709			709
Vesting of restricted securities (in shares)		1
Vesting of restricted securities	0
Repurchase of ordinary shares (in shares)			(898)
Repurchase of ordinary shares	(35,175)		$ (35,175)
Retirement of ordinary shares	0		15		(15)
Share-based compensation	6,084			6,084
Net income	8,431				8,431
Other comprehensive income (loss)	(15,992)					(15,992)
Ending Balance at Mar. 31, 2020	$ 2,537,797	$ 2,212	$ (784,596)	$ 1,731,884	$ 1,624,773	$ (36,476)
Ending Balance (in shares) at Mar. 31, 2020		172,596	(15,631)

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements reflect the financial position, results of operations, comprehensive (loss)/income, cash flows, and changes in shareholders' equity of Sensata Technologies Holding plc, a public limited company incorporated under the laws of England and Wales, and its wholly-owned subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," or "us." The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019 . All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated.

New Accounting Standards

New Accounting Standards	3 Months Ended
	Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Standards	New Accounting Standards There are no recently issued accounting standards that have been adopted in the current period or will be adopted in future periods that have had or are expected to have a material impact on our consolidated financial position or results of operations.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2020
Revenue Recognition and Deferred Revenue [Abstract]
Revenue Recognition	Revenue Recognition The following table presents net revenue disaggregated by segment and end market for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 For the three months ended March 31, 2019 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 437,703 $ 8,236 $ 445,939 $ 492,015 $ 11,428 $ 503,443 HVOR (1) 130,986 — 130,986 148,013 — 148,013 Industrial — 80,599 80,599 — 92,641 92,641 Appliance and HVAC (2) — 45,396 45,396 — 51,704 51,704 Aerospace — 42,124 42,124 — 42,979 42,979 Other — 29,225 29,225 — 31,719 31,719 Total $ 568,689 $ 205,580 $ 774,269 $ 640,028 $ 230,471 $ 870,499 ________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning

Share-Based Payment Plans

Share-Based Payment Plans	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Share-Based Payment Plans	Share-Based Payment Plans The following table presents the components of non-cash compensation expense related to our equity awards for the three months ended March 31, 2020 and 2019 . For the three months ended March 31, 2020 March 31, 2019 Stock options $ 2,489 $ 1,524 Restricted securities 3,595 4,416 Share-based compensation expense $ 6,084 $ 5,940

Restructuring and Other Charges

Restructuring and Other Charges, Net	3 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges, Net	Restructuring and Other Charges, Net The following table presents the components of restructuring and other charges, net for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 Severance costs, net (1) $ 3,897 $ 2,855 Other (2) 601 2,454 Restructuring and other charges, net $ 4,498 $ 5,309 ___________________________________ (1) Severance costs, net for the three months ended March 31, 2020 were primarily related to termination benefits arising from the shutdown and relocation of an operating site in Northern Ireland. Severance costs for the three months ended March 31, 2019 were primarily related to limited workforce reductions of manufacturing, engineering, and administrative positions. (2) Other charges in the three months ended March 31, 2020 and 2019 were primarily related to deferred compensation incurred in connection with the acquisition of GIGAVAC, LLC. The following table presents changes to the severance portion of our restructuring liability during the three months ended March 31, 2020 : Severance Balance at December 31, 2019 $ 14,779 Charges, net of reversals 3,897 Payments (5,356 ) Foreign currency remeasurement (500 ) Balance at March 31, 2020 $ 12,820

Other, Net

Other, Net	3 Months Ended
	Mar. 31, 2020
Other Income and Expenses [Abstract]
Other, Net	Other, Net The following table presents the components of other, net for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 Currency remeasurement gain on net monetary assets $ 1,553 $ 1,865 (Loss)/gain on foreign currency forward contracts (3,781 ) 478 (Loss)/gain on commodity forward contracts (5,575 ) 1,123 Net periodic benefit cost, excluding service cost (4,381 ) (287 ) Other (97 ) 10 Other, net $ (12,281 ) $ 3,189

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table presents the (benefit from)/provision for income taxes for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 (Benefit from)/provision for income taxes $ (1,516 ) $ 21,467 The decrease in total tax from the prior period was predominantly related to the overall decrease in income before tax as impacted by the mix of profits in the various jurisdictions in which we operate. In response to the global financial and health crisis caused by the coronavirus pandemic ("COVID-19"), the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") on March 27, 2020. Federal limitations on interest deductions were reduced in connection with this legislation, and we recorded a deferred tax benefit of $7.5 million in the three months ended March 31, 2020 , as we were able to utilize additional interest expense that was previously subject to a valuation allowance. The (benefit from)/provision for income taxes consists of: • current tax expense, which relates primarily to our profitable operations in non-U.S. tax jurisdictions and withholding taxes related to management fees, royalties, and the repatriation of foreign earnings; and • deferred tax expense (or benefit), which represents adjustments in book-to-tax basis differences primarily related to (1) the step-up in fair value of fixed and intangible assets acquired in connection with business combination transactions, (2) changes in net operating loss carryforwards, (3) changes in tax rates, and (4) changes in our assessment of the realizability of our deferred tax assets.

Net Income per Share

Net Income per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Income per Share	Net Income per Share Basic and diluted net income per share are calculated by dividing net income by the number of basic and diluted weighted-average ordinary shares outstanding during the period. For the three months ended March 31, 2020 and 2019 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows: For the three months ended March 31, 2020 March 31, 2019 Basic weighted-average ordinary shares outstanding 157,599 163,247 Dilutive effect of stock options 334 635 Dilutive effect of unvested restricted securities 452 639 Diluted weighted-average ordinary shares outstanding 158,385 164,521 Net income and net income per share are presented in the condensed consolidated statements of operations. Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because either they would have had an anti–dilutive effect on net income per share or they related to equity awards that were contingently issuable for which the contingency had not been satisfied. These potential ordinary shares were as follows: For the three months ended March 31, 2020 March 31, 2019 Anti-dilutive shares excluded 1,385 1,013 Contingently issuable shares excluded 596 477

Inventories

Inventories	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories The following table presents the components of inventories as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 Finished goods $ 205,819 $ 197,531 Work-in-process 100,057 104,007 Raw materials 208,398 205,140 Inventories $ 514,274 $ 506,678

Pension and Other Post-Retireme

Pension and Other Post-Retirement Benefits	3 Months Ended
	Mar. 31, 2020
Retirement Benefits [Abstract]
Pension and Other Post-Retirement Benefits	Pension and Other Post-Retirement Benefits The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended March 31, 2020 and 2019 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2020 2019 2020 2019 2020 2019 2020 2019 Service cost $ — $ — $ 2 $ 2 $ 769 $ 731 $ 771 $ 733 Interest cost 267 399 37 53 315 338 619 790 Expected return on plan assets (433 ) (451 ) — — (174 ) (175 ) (607 ) (626 ) Amortization of net loss 295 245 10 11 236 191 541 447 Amortization of prior service (credit)/cost — — (196 ) (327 ) 2 3 (194 ) (324 ) Loss on settlement 4,022 — — — — — 4,022 — Net periodic benefit cost/(credit) $ 4,151 $ 193 $ (147 ) $ (261 ) $ 1,148 $ 1,088 $ 5,152 $ 1,020 Components of net periodic benefit cost/(credit) other than service cost are presented in other, net. Refer to Note 6, "Other, Net."

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	Debt Our long-term debt and finance lease and other financing obligations as of March 31, 2020 and December 31, 2019 consisted of the following: Maturity Date March 31, 2020 December 31, 2019 Term Loan September 20, 2026 $ 459,568 $ 460,725 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes February 15, 2026 750,000 750,000 4.375% Senior Notes February 15, 2030 450,000 450,000 Less: discount (11,220 ) (11,758 ) Less: deferred financing costs (23,359 ) (24,452 ) Less: current portion (4,630 ) (4,630 ) Long-term debt, net $ 3,220,359 $ 3,219,885 Finance lease and other financing obligations $ 30,745 $ 31,098 Less: current portion (2,465 ) (2,288 ) Finance lease and other financing obligations, less current portion $ 28,280 $ 28,810 As of March 31, 2020 there was $416.1 million available under our $420.0 million revolving credit facility (the "Revolving Credit Facility"), net of $3.9 million of obligations related to outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of March 31, 2020 , no amounts had been drawn against these outstanding letters of credit. In order to enhance our financial flexibility in light of COVID-19, we executed a $400.0 million drawdown on the Revolving Credit Facility on April 1, 2020 . Accrued Interest Accrued interest associated with our outstanding debt is included as a component of accrued expenses and other current liabilities in the condensed consolidated balance sheets. As of March 31, 2020 and December 31, 2019 , accrued interest totaled $47.1 million and $42.8 million , respectively.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are a defendant in a lawsuit, Wasica Finance Gmbh et al v. Schrader International Inc. et al, Case No. 13-1353-CPS, U.S.D.C., Delaware, in which the claimant alleges infringement of their patent (US 5,602,524) in connection with certain of our tire pressure monitoring system products. The patent in question has expired, and as a result, the claimant seeks damages for past alleged infringement with interest and costs. The asserted patent is the U.S. counterpart of a German patent that had been previously asserted against Schrader. Schrader succeeded in proving that German patent to be invalid. On February 14, 2020 , the federal jury trial related to this lawsuit concluded, and the jury found Schrader International Inc. liable for damages in the amount of $31.2 million . As a result, we recorded a loss of $29.2 million in the three months ended March 31, 2020 through cost of revenue. We continue to deny any wrongdoing, have filed post-trial motions, and intend to appeal the jury's decision, including any final circuit court order against us. As of March 31, 2020 , we have recorded an accrual of $31.2 million

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Shareholders' Equity	Shareholders' Equity Treasury Shares From time to time, our Board of Directors has authorized various share repurchase programs. The authorized amount of our various share repurchase programs may be modified or terminated by our Board of Directors at any time. We currently have an authorized $500.0 million share repurchase program under which approximately $302.3 million remained available as of March 31, 2020 . On April 2, 2020 , we announced a temporary suspension of this share repurchase program to enhance our financial flexibility in light of the uncertainties surrounding COVID-19. Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss for the three months ended March 31, 2020 were as follows: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance at December 31, 2019 $ 16,546 $ (37,030 ) $ (20,484 ) Other comprehensive loss before reclassifications, net of tax (13,041 ) — (13,041 ) Reclassifications from accumulated other comprehensive loss, net of tax (6,293 ) 3,342 (2,951 ) Other comprehensive (loss)/income (19,334 ) 3,342 (15,992 ) Balance at March 31, 2020 $ (2,788 ) $ (33,688 ) $ (36,476 ) The details of the amounts reclassified from accumulated other comprehensive loss for the three months ended March 31, 2020 and 2019 are as follows: For the three months ended March 31, Component 2020 2019 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ (6,623 ) $ (3,219 ) Net revenue (1) Foreign currency forward contracts (1,768 ) (128 ) Cost of revenue (1) Total, before taxes (8,391 ) (3,347 ) Income before taxes Income tax effect 2,098 686 (Benefit from)/provision for income taxes Total, net of taxes $ (6,293 ) $ (2,661 ) Net income Defined benefit and retiree healthcare plans $ 4,369 $ 123 Other, net (2) Income tax effect (1,027 ) (40 ) (Benefit from)/provision for income taxes Total, net of taxes $ 3,342 $ 83 Net income __________________________ (1) Refer to Note 15, "Derivative Instruments and Hedging Activities" for additional information on amounts to be reclassified from accumulated other comprehensive loss in future periods. (2) Refer to Note 10, "Pension and Other Post-Retirement Benefits" for additional information on net periodic benefit cost/(credit).

Fair Value Measures

Fair Value Measures	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measures	Fair Value Measures Measured on a Recurring Basis The fair values of our assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019 are shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. March 31, 2020 December 31, 2019 Assets Foreign currency forward contracts $ 20,095 $ 23,561 Commodity forward contracts 2,079 3,623 Total $ 22,174 $ 27,184 Liabilities Foreign currency forward contracts $ 24,052 $ 1,959 Commodity forward contracts 4,993 462 Total $ 29,045 $ 2,421 Measured on a Nonrecurring Basis We evaluated our goodwill and other indefinite-lived intangible assets for impairment as of October 1, 2019 and determined that they were not impaired. As of March 31, 2020 , we have assessed the market impact of COVID-19, including the resulting impact on our forecasts, and have determined that our intangible assets (including goodwill) were not impaired as of March 31, 2020 . Financial Instruments Not Recorded at Fair Value The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019 . All fair value measures presented are categorized in Level 2 of the fair value hierarchy. March 31, 2020 December 31, 2019 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Liabilities Term Loan $ 459,568 $ 436,590 $ 460,725 $ 464,181 4.875% Senior Notes $ 500,000 $ 480,000 $ 500,000 $ 532,500 5.625% Senior Notes $ 400,000 $ 384,000 $ 400,000 $ 444,000 5.0% Senior Notes $ 700,000 $ 665,000 $ 700,000 $ 759,500 6.25% Senior Notes $ 750,000 $ 727,500 $ 750,000 $ 808,125 4.375% Senior Notes $ 450,000 $ 396,000 $ 450,000 $ 457,875 ___________________________________ (1) Excluding any related debt discounts and deferred financing costs. In addition to the above, we hold certain equity investments that do not have readily determinable fair values for which we use the measurement alternative prescribed in FASB ASC Topic 321, Investments - Equity Securities. Such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. There were no impairments or changes resulting from observable transactions for any of these investments, and no adjustments have been made to their carrying values. Refer to the table below for a detail of the carrying values of these investments, each of which are presented in other assets. March 31, 2020 December 31, 2019 Quanergy Systems, Inc $ 50,000 $ 50,000 Lithium Balance — 3,700 Total $ 50,000 $ 53,700

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities Hedges of Foreign Currency Risk For the three months ended March 31, 2020 and 2019 , amounts excluded from the assessment of effectiveness of our foreign currency forward contracts that are designated as cash flow hedges were not material. As of March 31, 2020 , we estimate that $3.5 million of net gains will be reclassified from accumulated other comprehensive loss to earnings during the twelve-month period ending March 31, 2021 . As of March 31, 2020 , we had the following outstanding foreign currency forward contracts: Notional (in millions) Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted-Average Strike Rate Hedge Designation (1) 30.0 EUR March 27, 2020 April 30, 2020 Euro ("EUR") to USD 1.10 USD Not designated 325.7 EUR Various from May 2018 to March 2020 Various from April 2020 to February 2022 EUR to USD 1.16 USD Cash flow hedge 437.0 CNY March 26, 2020 April 30, 2020 USD to Chinese Renminbi ("CNY") 7.12 CNY Not designated 804.6 CNY Various from December 2019 to January 2020 Various from April to December 2020 USD to CNY 6.99 CNY Cash flow hedge 498.0 JPY March 27, 2020 April 30, 2020 USD to Japanese Yen ("JPY") 107.94 JPY Not designated 22,742.4 KRW Various from May 2018 to March 2020 Various from April 2020 to February 2022 USD to Korean Won ("KRW") 1,151.92 KRW Cash flow hedge 16.0 MYR March 26, 2020 April 30, 2020 USD to Malaysian Ringgit ("MYR") 4.31 MYR Not designated 202.0 MXN March 27, 2020 April 30, 2020 USD to Mexican Peso ("MXN") 23.53 MXN Not designated 2,961.0 MXN Various from May 2018 to March 2020 Various from April 2020 to February 2022 USD to MXN 21.36 MXN Cash flow hedge 2.0 GBP March 27, 2020 April 30, 2020 British Pound Sterling ("GBP") to USD 1.23 USD Not Designated 53.7 GBP Various from May 2018 to March 2020 Various from April 2020 to February 2022 GBP to USD 1.29 USD Cash flow hedge _________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes. Hedges of Commodity Risk As of March 31, 2020 , we had the following outstanding commodity forward contracts, none of which were designated for hedge accounting treatment in accordance with FASB ASC Topic 815, Derivatives and Hedging : Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 850,249 troy oz. April 2020 - February 2022 $16.65 Gold 7,733 troy oz. April 2020 - February 2022 $1,457.41 Nickel 221,697 pounds April 2020 - February 2022 $6.16 Aluminum 3,103,095 pounds April 2020 - February 2022 $0.87 Copper 2,290,867 pounds April 2020 - February 2022 $2.69 Platinum 7,821 troy oz. April 2020 - February 2022 $896.59 Palladium 942 troy oz. April 2020 - February 2022 $1,620.30 Financial Instrument Presentation The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019 : Asset Derivatives Liability Derivatives Balance Sheet Location March 31, 2020 December 31, 2019 Balance Sheet Location March 31, 2020 December 31, 2019 Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 17,224 $ 20,957 Accrued expenses and other current liabilities $ 17,139 $ 1,055 Foreign currency forward contracts Other assets 2,840 2,530 Other long-term liabilities 6,504 428 Total $ 20,064 $ 23,487 $ 23,643 $ 1,483 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 1,635 $ 3,069 Accrued expenses and other current liabilities $ 3,603 $ 394 Commodity forward contracts Other assets 444 554 Other long-term liabilities 1,390 68 Foreign currency forward contracts Prepaid expenses and other current assets 31 74 Accrued expenses and other current liabilities 409 476 Total $ 2,110 $ 3,697 $ 5,402 $ 938 These fair value measurements are all categorized within Level 2 of the fair value hierarchy. The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive (loss)/income for the three months ended March 31, 2020 and 2019 : Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive (Loss)/Income Location of Net Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income 2020 2019 2020 2019 Foreign currency forward contracts $ 12,544 $ 9,118 Net revenue $ 6,623 $ 3,219 Foreign currency forward contracts $ (29,630 ) $ 6,078 Cost of revenue $ 1,768 $ 128 Derivatives not designated as Amount of (Loss)/Gain Recognized in Net Income Location of (Loss)/Gain Recognized in Net Income 2020 2019 Commodity forward contracts $ (5,575 ) $ 1,123 Other, net Foreign currency forward contracts $ (3,781 ) $ 478 Other, net Credit Risk Related Contingent Features We have agreements with certain of our derivative counterparties that contain a provision whereby if we default on our indebtedness and repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations. As of March 31, 2020 , the termination value of outstanding derivatives in a liability position, excluding any adjustment for non-performance risk, was $29.3 million . As of March 31, 2020 , we had no

Acquisitions and Divestitures

Acquisitions and Divestitures	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Acquisitions and Divestitures	Acquisitions On September 13, 2019, we completed one acquisition for approximately $30 million

Segment Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We operate in, and report financial information for, the following two reportable segments, Performance Sensing and Sensing Solutions, each of which is also an operating segment. Our operating segments are businesses that we manage as components of an enterprise, for which separate financial information is evaluated regularly by our chief operating decision maker in deciding how to allocate resources and assess performance. An operating segment’s performance is primarily evaluated based on segment operating income, which excludes amortization of intangible assets, restructuring and other charges, net, and certain corporate costs/credits not associated with the operations of the segment, including share-based compensation expense and a portion of depreciation expense associated with assets recorded in connection with acquisitions. Corporate and other costs excluded from an operating segment’s performance are separately stated below and also include costs that are related to functional areas, such as finance, information technology, legal, and human resources. We believe that segment operating income, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, this measure should be considered in addition to, and not as a substitute for, or superior to, operating income or other measures of financial performance prepared in accordance with U.S. GAAP. The accounting policies of each of our reporting segments are materially consistent with those in the summary of significant accounting policies as described in Note 2, "Significant Accounting Policies" included in our Annual Report on Form 10-K for the year ended December 31, 2019 . The following table presents net revenue and segment operating income for the reported segments and other operating results not allocated to the reported segments for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 Net revenue: Performance Sensing $ 568,689 $ 640,028 Sensing Solutions 205,580 230,471 Total net revenue $ 774,269 $ 870,499 Segment operating income (as defined above): Performance Sensing $ 129,062 $ 150,509 Sensing Solutions 55,949 74,969 Total segment operating income 185,011 225,478 Corporate and other (88,822 ) (41,430 ) Amortization of intangible assets (33,092 ) (36,143 ) Restructuring and other charges, net (4,498 ) (5,309 ) Operating income 58,599 142,596 Interest expense, net (39,403 ) (39,253 ) Other, net (12,281 ) 3,189 Income before taxes $ 6,915 $ 106,532

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On April 2, 2020, we announced a series of actions taken in response to COVID-19. These actions are designed to protect the health and safety of our employees, enable us to continue to serve critical customer needs, and further enhance our financial flexibility. Actions taken to enhance our financial flexibility included a temporary suspension of our share repurchase program and a $400.0 million drawdown on the Revolving Credit Facility on April 1, 2020, leaving us with cash on hand of approximately $1.2 billion

New Accounting Standards (Polic

New Accounting Standards (Policies)	3 Months Ended
	Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019 . All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue Recognition and Deferred Revenue [Abstract]
Disaggregation of Revenue	The following table presents net revenue disaggregated by segment and end market for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 For the three months ended March 31, 2019 Performance Sensing Sensing Solutions Total Performance Sensing Sensing Solutions Total Automotive $ 437,703 $ 8,236 $ 445,939 $ 492,015 $ 11,428 $ 503,443 HVOR (1) 130,986 — 130,986 148,013 — 148,013 Industrial — 80,599 80,599 — 92,641 92,641 Appliance and HVAC (2) — 45,396 45,396 — 51,704 51,704 Aerospace — 42,124 42,124 — 42,979 42,979 Other — 29,225 29,225 — 31,719 31,719 Total $ 568,689 $ 205,580 $ 774,269 $ 640,028 $ 230,471 $ 870,499 ________________________ (1) Heavy vehicle and off-road (2) Heating, ventilation and air conditioning

Share-Based Payment Plans (Tabl

Share-Based Payment Plans (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of non-cash compensation expense related to equity awards	The following table presents the components of non-cash compensation expense related to our equity awards for the three months ended March 31, 2020 and 2019 . For the three months ended March 31, 2020 March 31, 2019 Stock options $ 2,489 $ 1,524 Restricted securities 3,595 4,416 Share-based compensation expense $ 6,084 $ 5,940

Restructuring and Other Charg_2

Restructuring and Other Charges, Net (Tables)	3 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and other charges, net	The following table presents the components of restructuring and other charges, net for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 Severance costs, net (1) $ 3,897 $ 2,855 Other (2) 601 2,454 Restructuring and other charges, net $ 4,498 $ 5,309 ___________________________________ (1) Severance costs, net for the three months ended March 31, 2020 were primarily related to termination benefits arising from the shutdown and relocation of an operating site in Northern Ireland. Severance costs for the three months ended March 31, 2019 were primarily related to limited workforce reductions of manufacturing, engineering, and administrative positions. (2) Other charges in the three months ended March 31, 2020 and 2019 were primarily related to deferred compensation incurred in connection with the acquisition of GIGAVAC, LLC.
Changes to restructuring liability	The following table presents changes to the severance portion of our restructuring liability during the three months ended March 31, 2020 : Severance Balance at December 31, 2019 $ 14,779 Charges, net of reversals 3,897 Payments (5,356 ) Foreign currency remeasurement (500 ) Balance at March 31, 2020 $ 12,820

Other, Net (Tables)

Other, Net (Tables)	3 Months Ended
	Mar. 31, 2020
Other Income and Expenses [Abstract]
Schedule of other, net	The following table presents the components of other, net for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 Currency remeasurement gain on net monetary assets $ 1,553 $ 1,865 (Loss)/gain on foreign currency forward contracts (3,781 ) 478 (Loss)/gain on commodity forward contracts (5,575 ) 1,123 Net periodic benefit cost, excluding service cost (4,381 ) (287 ) Other (97 ) 10 Other, net $ (12,281 ) $ 3,189

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The following table presents the (benefit from)/provision for income taxes for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 (Benefit from)/provision for income taxes $ (1,516 ) $ 21,467

Net Income per Share (Tables)

Net Income per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of weighted-average ordinary shares outstanding	For the three months ended March 31, 2020 and 2019 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows: For the three months ended March 31, 2020 March 31, 2019 Basic weighted-average ordinary shares outstanding 157,599 163,247 Dilutive effect of stock options 334 635 Dilutive effect of unvested restricted securities 452 639 Diluted weighted-average ordinary shares outstanding 158,385 164,521
Schedule of antidilutive securities	These potential ordinary shares were as follows: For the three months ended March 31, 2020 March 31, 2019 Anti-dilutive shares excluded 1,385 1,013 Contingently issuable shares excluded 596 477

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Components of inventories	The following table presents the components of inventories as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 Finished goods $ 205,819 $ 197,531 Work-in-process 100,057 104,007 Raw materials 208,398 205,140 Inventories $ 514,274 $ 506,678

Pension and Other Post-Retire_2

Pension and Other Post-Retirement Benefits (Tables)	3 Months Ended
	Mar. 31, 2020
Retirement Benefits [Abstract]
Schedule of components of net periodic benefit cost	The components of net periodic benefit cost/(credit) associated with our defined benefit and retiree healthcare plans for the three months ended March 31, 2020 and 2019 were as follows: U.S. Plans Non-U.S. Plans Defined Benefit Retiree Healthcare Defined Benefit Total 2020 2019 2020 2019 2020 2019 2020 2019 Service cost $ — $ — $ 2 $ 2 $ 769 $ 731 $ 771 $ 733 Interest cost 267 399 37 53 315 338 619 790 Expected return on plan assets (433 ) (451 ) — — (174 ) (175 ) (607 ) (626 ) Amortization of net loss 295 245 10 11 236 191 541 447 Amortization of prior service (credit)/cost — — (196 ) (327 ) 2 3 (194 ) (324 ) Loss on settlement 4,022 — — — — — 4,022 — Net periodic benefit cost/(credit) $ 4,151 $ 193 $ (147 ) $ (261 ) $ 1,148 $ 1,088 $ 5,152 $ 1,020

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of long-term debt and capital lease and other financing obligations	Our long-term debt and finance lease and other financing obligations as of March 31, 2020 and December 31, 2019 consisted of the following: Maturity Date March 31, 2020 December 31, 2019 Term Loan September 20, 2026 $ 459,568 $ 460,725 4.875% Senior Notes October 15, 2023 500,000 500,000 5.625% Senior Notes November 1, 2024 400,000 400,000 5.0% Senior Notes October 1, 2025 700,000 700,000 6.25% Senior Notes February 15, 2026 750,000 750,000 4.375% Senior Notes February 15, 2030 450,000 450,000 Less: discount (11,220 ) (11,758 ) Less: deferred financing costs (23,359 ) (24,452 ) Less: current portion (4,630 ) (4,630 ) Long-term debt, net $ 3,220,359 $ 3,219,885 Finance lease and other financing obligations $ 30,745 $ 31,098 Less: current portion (2,465 ) (2,288 ) Finance lease and other financing obligations, less current portion $ 28,280 $ 28,810

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Roll forward of components of Accumulated other comprehensive loss	The components of accumulated other comprehensive loss for the three months ended March 31, 2020 were as follows: Cash Flow Hedges Defined Benefit and Retiree Healthcare Plans Accumulated Other Comprehensive Loss Balance at December 31, 2019 $ 16,546 $ (37,030 ) $ (20,484 ) Other comprehensive loss before reclassifications, net of tax (13,041 ) — (13,041 ) Reclassifications from accumulated other comprehensive loss, net of tax (6,293 ) 3,342 (2,951 ) Other comprehensive (loss)/income (19,334 ) 3,342 (15,992 ) Balance at March 31, 2020 $ (2,788 ) $ (33,688 ) $ (36,476 )
Summary of amounts reclassified from Accumulated other comprehensive loss	The details of the amounts reclassified from accumulated other comprehensive loss for the three months ended March 31, 2020 and 2019 are as follows: For the three months ended March 31, Component 2020 2019 Derivative instruments designated and qualifying as cash flow hedges: Foreign currency forward contracts $ (6,623 ) $ (3,219 ) Net revenue (1) Foreign currency forward contracts (1,768 ) (128 ) Cost of revenue (1) Total, before taxes (8,391 ) (3,347 ) Income before taxes Income tax effect 2,098 686 (Benefit from)/provision for income taxes Total, net of taxes $ (6,293 ) $ (2,661 ) Net income Defined benefit and retiree healthcare plans $ 4,369 $ 123 Other, net (2) Income tax effect (1,027 ) (40 ) (Benefit from)/provision for income taxes Total, net of taxes $ 3,342 $ 83 Net income __________________________ (1) Refer to Note 15, "Derivative Instruments and Hedging Activities" for additional information on amounts to be reclassified from accumulated other comprehensive loss in future periods. (2) Refer to Note 10, "Pension and Other Post-Retirement Benefits" for additional information on net periodic benefit cost/(credit).

Fair Value Measures (Tables)

Fair Value Measures (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities measured at fair value on a recurring basis	The fair values of our assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019 are shown in the below table. All fair value measures presented are categorized in Level 2 of the fair value hierarchy. March 31, 2020 December 31, 2019 Assets Foreign currency forward contracts $ 20,095 $ 23,561 Commodity forward contracts 2,079 3,623 Total $ 22,174 $ 27,184 Liabilities Foreign currency forward contracts $ 24,052 $ 1,959 Commodity forward contracts 4,993 462 Total $ 29,045 $ 2,421
Information about carrying values and fair values of financial instruments not recorded at fair value	The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019 . All fair value measures presented are categorized in Level 2 of the fair value hierarchy. March 31, 2020 December 31, 2019 Carrying Value (1) Fair Value Carrying Value (1) Fair Value Liabilities Term Loan $ 459,568 $ 436,590 $ 460,725 $ 464,181 4.875% Senior Notes $ 500,000 $ 480,000 $ 500,000 $ 532,500 5.625% Senior Notes $ 400,000 $ 384,000 $ 400,000 $ 444,000 5.0% Senior Notes $ 700,000 $ 665,000 $ 700,000 $ 759,500 6.25% Senior Notes $ 750,000 $ 727,500 $ 750,000 $ 808,125 4.375% Senior Notes $ 450,000 $ 396,000 $ 450,000 $ 457,875 ___________________________________ (1) Excluding any related debt discounts and deferred financing costs.
Equity securities without readily determinable fair value	Refer to the table below for a detail of the carrying values of these investments, each of which are presented in other assets. March 31, 2020 December 31, 2019 Quanergy Systems, Inc $ 50,000 $ 50,000 Lithium Balance — 3,700 Total $ 50,000 $ 53,700

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of outstanding derivative instruments	As of March 31, 2020 , we had the following outstanding commodity forward contracts, none of which were designated for hedge accounting treatment in accordance with FASB ASC Topic 815, Derivatives and Hedging : Commodity Notional Remaining Contracted Periods Weighted-Average Strike Price Per Unit Silver 850,249 troy oz. April 2020 - February 2022 $16.65 Gold 7,733 troy oz. April 2020 - February 2022 $1,457.41 Nickel 221,697 pounds April 2020 - February 2022 $6.16 Aluminum 3,103,095 pounds April 2020 - February 2022 $0.87 Copper 2,290,867 pounds April 2020 - February 2022 $2.69 Platinum 7,821 troy oz. April 2020 - February 2022 $896.59 Palladium 942 troy oz. April 2020 - February 2022 $1,620.30 As of March 31, 2020 , we had the following outstanding foreign currency forward contracts: Notional (in millions) Effective Date(s) Maturity Date(s) Index (Exchange Rates) Weighted-Average Strike Rate Hedge Designation (1) 30.0 EUR March 27, 2020 April 30, 2020 Euro ("EUR") to USD 1.10 USD Not designated 325.7 EUR Various from May 2018 to March 2020 Various from April 2020 to February 2022 EUR to USD 1.16 USD Cash flow hedge 437.0 CNY March 26, 2020 April 30, 2020 USD to Chinese Renminbi ("CNY") 7.12 CNY Not designated 804.6 CNY Various from December 2019 to January 2020 Various from April to December 2020 USD to CNY 6.99 CNY Cash flow hedge 498.0 JPY March 27, 2020 April 30, 2020 USD to Japanese Yen ("JPY") 107.94 JPY Not designated 22,742.4 KRW Various from May 2018 to March 2020 Various from April 2020 to February 2022 USD to Korean Won ("KRW") 1,151.92 KRW Cash flow hedge 16.0 MYR March 26, 2020 April 30, 2020 USD to Malaysian Ringgit ("MYR") 4.31 MYR Not designated 202.0 MXN March 27, 2020 April 30, 2020 USD to Mexican Peso ("MXN") 23.53 MXN Not designated 2,961.0 MXN Various from May 2018 to March 2020 Various from April 2020 to February 2022 USD to MXN 21.36 MXN Cash flow hedge 2.0 GBP March 27, 2020 April 30, 2020 British Pound Sterling ("GBP") to USD 1.23 USD Not Designated 53.7 GBP Various from May 2018 to March 2020 Various from April 2020 to February 2022 GBP to USD 1.29 USD Cash flow hedge _________________________ (1) Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes.
Schedule of fair values of derivative financial instruments and their classification in balance sheets	The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019 : Asset Derivatives Liability Derivatives Balance Sheet Location March 31, 2020 December 31, 2019 Balance Sheet Location March 31, 2020 December 31, 2019 Derivatives designated as hedging instruments Foreign currency forward contracts Prepaid expenses and other current assets $ 17,224 $ 20,957 Accrued expenses and other current liabilities $ 17,139 $ 1,055 Foreign currency forward contracts Other assets 2,840 2,530 Other long-term liabilities 6,504 428 Total $ 20,064 $ 23,487 $ 23,643 $ 1,483 Derivatives not designated as hedging instruments Commodity forward contracts Prepaid expenses and other current assets $ 1,635 $ 3,069 Accrued expenses and other current liabilities $ 3,603 $ 394 Commodity forward contracts Other assets 444 554 Other long-term liabilities 1,390 68 Foreign currency forward contracts Prepaid expenses and other current assets 31 74 Accrued expenses and other current liabilities 409 476 Total $ 2,110 $ 3,697 $ 5,402 $ 938
Schedule of effect of derivative financial instruments on statements of operations	The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive (loss)/income for the three months ended March 31, 2020 and 2019 : Derivatives designated as Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive (Loss)/Income Location of Net Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income Amount of Net Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income 2020 2019 2020 2019 Foreign currency forward contracts $ 12,544 $ 9,118 Net revenue $ 6,623 $ 3,219 Foreign currency forward contracts $ (29,630 ) $ 6,078 Cost of revenue $ 1,768 $ 128 Derivatives not designated as Amount of (Loss)/Gain Recognized in Net Income Location of (Loss)/Gain Recognized in Net Income 2020 2019 Commodity forward contracts $ (5,575 ) $ 1,123 Other, net Foreign currency forward contracts $ (3,781 ) $ 478 Other, net

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of segment reporting information by segment	The following table presents net revenue and segment operating income for the reported segments and other operating results not allocated to the reported segments for the three months ended March 31, 2020 and 2019 : For the three months ended March 31, 2020 March 31, 2019 Net revenue: Performance Sensing $ 568,689 $ 640,028 Sensing Solutions 205,580 230,471 Total net revenue $ 774,269 $ 870,499 Segment operating income (as defined above): Performance Sensing $ 129,062 $ 150,509 Sensing Solutions 55,949 74,969 Total segment operating income 185,011 225,478 Corporate and other (88,822 ) (41,430 ) Amortization of intangible assets (33,092 ) (36,143 ) Restructuring and other charges, net (4,498 ) (5,309 ) Operating income 58,599 142,596 Interest expense, net (39,403 ) (39,253 ) Other, net (12,281 ) 3,189 Income before taxes $ 6,915 $ 106,532

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Net revenue	$ 774,269	$ 870,499
Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	568,689	640,028
Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	205,580	230,471
Automotive
Disaggregation of Revenue [Line Items]
Net revenue	445,939	503,443
Automotive | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	437,703	492,015
Automotive | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	8,236	11,428
HVOR
Disaggregation of Revenue [Line Items]
Net revenue	130,986	148,013
HVOR | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	130,986	148,013
HVOR | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Industrial
Disaggregation of Revenue [Line Items]
Net revenue	80,599	92,641
Industrial | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Industrial | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	80,599	92,641
Appliance and HVAC
Disaggregation of Revenue [Line Items]
Net revenue	45,396	51,704
Appliance and HVAC | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Appliance and HVAC | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	45,396	51,704
Aerospace
Disaggregation of Revenue [Line Items]
Net revenue	42,124	42,979
Aerospace | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Aerospace | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	42,124	42,979
Other
Disaggregation of Revenue [Line Items]
Net revenue	29,225	31,719
Other | Performance Sensing
Disaggregation of Revenue [Line Items]
Net revenue	0	0
Other | Sensing Solutions
Disaggregation of Revenue [Line Items]
Net revenue	$ 29,225	$ 31,719

Share-Based Payment Plans - Sha

Share-Based Payment Plans - Share-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 6,084	$ 5,940
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	2,489	1,524
Restricted securities
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 3,595	$ 4,416

Restructuring and Other Charg_3

Restructuring and Other Charges, Net - Schedule of Restructuring and Other Charges, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restructuring and Related Activities [Abstract]
Severance costs, net	$ 3,897	$ 2,855
Other	601	2,454
Restructuring and other charges, net	$ 4,498	$ 5,309

Restructuring and Other Charg_4

Restructuring and Other Charges, Net - Schedule of Changes to Restructuring Liability (Details) - Severance $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Restructuring Reserve [Roll Forward]
Balance at December 31, 2019	$ 14,779
Charges, net of reversals	3,897
Payments	(5,356)
Foreign currency remeasurement	(500)
Balance at March 31, 2020	$ 12,820

Other, Net (Details)

Other, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Other Income and Expenses [Abstract]
Currency remeasurement gain on net monetary assets	$ 1,553	$ 1,865
(Loss)/gain on foreign currency forward contracts	(3,781)	478
(Loss)/gain on commodity forward contracts	(5,575)	1,123
Net periodic benefit cost, excluding service cost	(4,381)	(287)
Other	(97)	10
Other, net	$ (12,281)	$ 3,189

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
(Benefit from)/provision for income taxes	$ (1,516)	$ 21,467
Deferred income tax benefit	$ 7,500

Net Income per Share - Schedule

Net Income per Share - Schedule of Weighted Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic weighted-average ordinary shares outstanding (in shares)	157,599	163,247
Dilutive effect of stock options (in shares)	334	635
Dilutive effect of unvested restricted securities (in shares)	452	639
Diluted weighted-average ordinary shares outstanding (in shares)	158,385	164,521

Net Income per Share - Schedu_2

Net Income per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Anti-dilutive shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,385	1,013
Contingently issuable shares excluded
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	596	477

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Inventory, Net [Abstract]
Finished goods	$ 205,819	$ 197,531
Work-in-process	100,057	104,007
Raw materials	208,398	205,140
Inventories	$ 514,274	$ 506,678

Pension and Other Post-Retire_3

Pension and Other Post-Retirement Benefits - Schedule of components of net periodic benefit cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	$ 771	$ 733
Interest cost	619	790
Expected return on plan assets	(607)	(626)
Amortization of net loss	541	447
Amortization of prior service (credit)/cost	(194)	(324)
Loss on settlement	4,022	0
Net periodic benefit cost/(credit)	5,152	1,020
U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	0	0
Interest cost	267	399
Expected return on plan assets	(433)	(451)
Amortization of net loss	295	245
Amortization of prior service (credit)/cost	0	0
Loss on settlement	4,022	0
Net periodic benefit cost/(credit)	4,151	193
U.S. Plans | Retiree Healthcare
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	2	2
Interest cost	37	53
Expected return on plan assets	0	0
Amortization of net loss	10	11
Amortization of prior service (credit)/cost	(196)	(327)
Loss on settlement	0	0
Net periodic benefit cost/(credit)	(147)	(261)
Non-U.S. Plans | Defined Benefit
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	769	731
Interest cost	315	338
Expected return on plan assets	(174)	(175)
Amortization of net loss	236	191
Amortization of prior service (credit)/cost	2	3
Loss on settlement	0	0
Net periodic benefit cost/(credit)	$ 1,148	$ 1,088

Debt - Debt Schedule (Details)

Debt - Debt Schedule (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Less: discount	$ (11,220)	$ (11,758)
Less: deferred financing costs	(23,359)	(24,452)
Less: current portion	(4,630)	(4,630)
Long-term debt, net	3,220,359	3,219,885
Finance lease and other financing obligations	30,745	31,098
Less: current portion	(2,465)	(2,288)
Finance lease and other financing obligations, less current portion	$ 28,280	28,810
4.875% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.875%
5.625% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.625%
5.0% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.00%
6.25% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	6.25%
4.375% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.375%
Secured Debt | Term Loan
Debt Instrument [Line Items]
Gross long-term debt	$ 459,568	460,725
Senior Notes | 4.875% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	500,000	500,000
Senior Notes | 5.625% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	400,000	400,000
Senior Notes | 5.0% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	700,000	700,000
Senior Notes | 6.25% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	750,000	750,000
Senior Notes | 4.375% Senior Notes
Debt Instrument [Line Items]
Gross long-term debt	$ 450,000	$ 450,000

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($) $ in Millions	Apr. 01, 2020	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Accrued interest		$ 47.1	$ 42.8
Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Amount available under revolving credit facility		416.1
Revolving credit facility		420
Letters of credit outstanding, amount		3.9
Line of Credit | Letter of Credit
Debt Instrument [Line Items]
Letters of credit outstanding, amount		$ 0
Subsequent Event | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term line of credit	$ 400

Commitments and Contingencies

Commitments and Contingencies (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Loss Contingencies [Line Items]
Loss on litigation judgment	$ 29,200	$ 0
Wasica Finance Gmbh et al v. Schrader International Inc.
Loss Contingencies [Line Items]
Loss contingency, accrual	31,200
Loss on litigation judgment	$ 29,200

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($)	Mar. 31, 2020	Jul. 30, 2019
Equity [Abstract]
Stock repurchase program, authorized amount		$ 500,000,000
Remaining amount under share repurchase program	$ 302,300,000

Shareholders' Equity - AOCI Rol

Shareholders' Equity - AOCI Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	$ 2,573,755	$ 2,608,434
Other comprehensive income	(15,992)	10,143
Ending Balance	2,537,797	2,564,371
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	16,546
Other comprehensive loss before reclassifications, net of tax	(13,041)
Reclassifications from accumulated other comprehensive loss, net of tax	(6,293)
Other comprehensive income	(19,334)
Ending Balance	(2,788)
Defined Benefit and Retiree Healthcare Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(37,030)
Other comprehensive loss before reclassifications, net of tax	0
Reclassifications from accumulated other comprehensive loss, net of tax	3,342
Other comprehensive income	3,342
Ending Balance	(33,688)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(20,484)	(26,178)
Other comprehensive loss before reclassifications, net of tax	(13,041)
Reclassifications from accumulated other comprehensive loss, net of tax	(2,951)
Other comprehensive income	(15,992)
Ending Balance	$ (36,476)	$ (16,035)

Shareholders' Equity - AOCI Rec

Shareholders' Equity - AOCI Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	$ 774,269	$ 870,499
Cost of revenue	566,406	580,806
Other, net	(12,281)	3,189
Income before taxes	6,915	106,532
(Benefit from)/provision for income taxes	1,516	(21,467)
Net income	8,431	85,065
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	(8,391)	(3,347)
(Benefit from)/provision for income taxes	2,098	686
Net income	(6,293)	(2,661)
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Derivative instruments designated and qualifying as cash flow hedges: | Foreign currency forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net revenue	(6,623)	(3,219)
Cost of revenue	(1,768)	(128)
(Gain)/Loss Reclassified from Accumulated Other Comprehensive Loss | Defined benefit and retiree healthcare plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other, net	4,369	123
(Benefit from)/provision for income taxes	(1,027)	(40)
Net income	$ 3,342	$ 83

Fair Value Measures - Schedule

Fair Value Measures - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Level 2 - Fair Value, Measurements, Recurring - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets
Foreign currency forward contracts	$ 20,095	$ 23,561
Commodity forward contracts	2,079	3,623
Total	22,174	27,184
Liabilities
Foreign currency forward contracts	24,052	1,959
Commodity forward contracts	4,993	462
Total	$ 29,045	$ 2,421

Fair Value Measures - Financial

Fair Value Measures - Financial Instruments Not Recorded at Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	4.875%
5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.625%
5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.00%
6.25% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	6.25%
Level 2 | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 436,590	$ 464,181
Level 2 | 4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	480,000	532,500
Level 2 | 5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	384,000	444,000
Level 2 | 5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	665,000	759,500
Level 2 | 6.25% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	727,500	808,125
Level 2 | 4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	396,000	457,875
Level 2 | Carrying Value | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	459,568	460,725
Level 2 | Carrying Value | 4.875% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	500,000	500,000
Level 2 | Carrying Value | 5.625% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	400,000	400,000
Level 2 | Carrying Value | 5.0% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	700,000	700,000
Level 2 | Carrying Value | 6.25% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	750,000	750,000
Level 2 | Carrying Value | 4.375% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 450,000	$ 450,000

Fair Value Measures - Equity In

Fair Value Measures - Equity Instruments without Readily Determinable Fair Values (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]
Equity investment	$ 50,000	$ 53,700
Quanergy Systems, Inc.
Schedule of Equity Method Investments [Line Items]
Equity investment	50,000	50,000
Lithium Balance A/S
Schedule of Equity Method Investments [Line Items]
Equity investment	$ 0	$ 3,700

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities - Narrative (Details)	Mar. 31, 2020USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Foreign currency cash flow gain to be reclassified during next 12 months	$ 3,500,000
Termination value of outstanding derivatives in a liability position	29,300,000
Collateral already posted, aggregate fair value	$ 0

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments (Details) - Mar. 31, 2020 € in Millions, ₩ in Millions, ¥ in Millions, ¥ in Millions, £ in Millions, RM in Millions, $ in Millions	EUR (€)oztlb$ / $$ / ¥€ / $$ / RM$ / ¥£ / $$ / ₩	KRW (₩)oztlb$ / $$ / ¥€ / $$ / RM$ / ¥£ / $$ / ₩	MXN ($)oztlb$ / $$ / ¥€ / $$ / RM$ / ¥£ / $$ / ₩	GBP (£)oztlb$ / $$ / ¥€ / $$ / RM$ / ¥£ / $$ / ₩	CNY (¥)oztlb$ / $$ / ¥€ / $$ / RM$ / ¥£ / $$ / ₩	MYR (RM)oztlb$ / $$ / ¥€ / $$ / RM$ / ¥£ / $$ / ₩	JPY (¥)oztlb$ / $$ / ¥€ / $$ / RM$ / ¥£ / $$ / ₩
Foreign currency forward contracts | Not designated | Euro (EUR) to USD
Hedges of Foreign Currency Risk
Notional | €	€ 30
Weighted-Average Strike Rate | € / $	1.10	1.10	1.10	1.10	1.10	1.10	1.10
Foreign currency forward contracts | Not designated | USD to Chinese Renminbi (CNY)
Hedges of Foreign Currency Risk
Notional | ¥					¥ 437
Weighted-Average Strike Rate | $ / ¥	7.12	7.12	7.12	7.12	7.12	7.12	7.12
Foreign currency forward contracts | Not designated | USD to Japanese Yen (JPY)
Hedges of Foreign Currency Risk
Notional | ¥							¥ 498
Weighted-Average Strike Rate | $ / ¥	107.94	107.94	107.94	107.94	107.94	107.94	107.94
Foreign currency forward contracts | Not designated | USD to Malaysian Ringgit (MYR)
Hedges of Foreign Currency Risk
Notional | RM						RM 16
Weighted-Average Strike Rate | $ / RM	4.31	4.31	4.31	4.31	4.31	4.31	4.31
Foreign currency forward contracts | Not designated | USD to Mexican Peso (MXN)
Hedges of Foreign Currency Risk
Notional | $			$ 202
Weighted-Average Strike Rate | $ / $	23.53	23.53	23.53	23.53	23.53	23.53	23.53
Foreign currency forward contracts | Not designated | British Pound Sterling (GBP) to USD
Hedges of Foreign Currency Risk
Notional | £				£ 2
Weighted-Average Strike Rate | £ / $	1.23	1.23	1.23	1.23	1.23	1.23	1.23
Foreign currency forward contracts | Cash flow hedge | Euro (EUR) to USD
Hedges of Foreign Currency Risk
Notional | €	€ 325.7
Weighted-Average Strike Rate | € / $	1.16	1.16	1.16	1.16	1.16	1.16	1.16
Foreign currency forward contracts | Cash flow hedge | USD to Chinese Renminbi (CNY)
Hedges of Foreign Currency Risk
Notional | ¥					¥ 804.6
Weighted-Average Strike Rate | $ / ¥	6.99	6.99	6.99	6.99	6.99	6.99	6.99
Foreign currency forward contracts | Cash flow hedge | USD to Korean Won (KRW)
Hedges of Foreign Currency Risk
Notional | ₩		₩ 22,742.4
Weighted-Average Strike Rate | $ / ₩	1,151.92	1,151.92	1,151.92	1,151.92	1,151.92	1,151.92	1,151.92
Foreign currency forward contracts | Cash flow hedge | USD to Mexican Peso (MXN)
Hedges of Foreign Currency Risk
Notional | $			$ 2,961
Weighted-Average Strike Rate | $ / $	21.36	21.36	21.36	21.36	21.36	21.36	21.36
Foreign currency forward contracts | Cash flow hedge | British Pound Sterling (GBP) to USD
Hedges of Foreign Currency Risk
Notional | £				£ 53.7
Weighted-Average Strike Rate | £ / $	1.29	1.29	1.29	1.29	1.29	1.29	1.29
Silver | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	16.65	16.65	16.65	16.65	16.65	16.65	16.65
Hedges of Commodity Risk
Notional	850,249	850,249	850,249	850,249	850,249	850,249	850,249
Gold | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	1,457.41	1,457.41	1,457.41	1,457.41	1,457.41	1,457.41	1,457.41
Hedges of Commodity Risk
Notional	7,733	7,733	7,733	7,733	7,733	7,733	7,733
Nickel | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	6.16	6.16	6.16	6.16	6.16	6.16	6.16
Hedges of Commodity Risk
Notional | lb	221,697	221,697	221,697	221,697	221,697	221,697	221,697
Aluminum | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	0.87	0.87	0.87	0.87	0.87	0.87	0.87
Hedges of Commodity Risk
Notional | lb	3,103,095	3,103,095	3,103,095	3,103,095	3,103,095	3,103,095	3,103,095
Copper | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	2.69	2.69	2.69	2.69	2.69	2.69	2.69
Hedges of Commodity Risk
Notional | lb	2,290,867	2,290,867	2,290,867	2,290,867	2,290,867	2,290,867	2,290,867
Platinum | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	896.59	896.59	896.59	896.59	896.59	896.59	896.59
Hedges of Commodity Risk
Notional	7,821	7,821	7,821	7,821	7,821	7,821	7,821
Palladium | Not designated
Hedges of Foreign Currency Risk
Weighted-Average Strike Rate	1,620.30	1,620.30	1,620.30	1,620.30	1,620.30	1,620.30	1,620.30
Hedges of Commodity Risk
Notional	942	942	942	942	942	942	942

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities - Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Cash flow hedge
Derivatives, Fair Value [Line Items]
Asset Derivatives	$ 20,064	$ 23,487
Liability Derivatives	23,643	1,483
Not designated
Derivatives, Fair Value [Line Items]
Asset Derivatives	2,110	3,697
Liability Derivatives	5,402	938
Foreign currency forward contracts | Cash flow hedge | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	17,224	20,957
Foreign currency forward contracts | Cash flow hedge | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	2,840	2,530
Foreign currency forward contracts | Cash flow hedge | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	17,139	1,055
Foreign currency forward contracts | Cash flow hedge | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	6,504	428
Foreign currency forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	31	74
Foreign currency forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	409	476
Commodity forward contracts | Not designated | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	1,635	3,069
Commodity forward contracts | Not designated | Other assets
Derivatives, Fair Value [Line Items]
Asset Derivatives	444	554
Commodity forward contracts | Not designated | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	3,603	394
Commodity forward contracts | Not designated | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Liability Derivatives	$ 1,390	$ 68

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities - Income Statement Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Foreign currency forward contracts | Net revenue | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive (Loss)/Income	$ 12,544	$ 9,118
Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income	6,623	3,219
Foreign currency forward contracts | Cost of revenue | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive (Loss)/Income	(29,630)	6,078
Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income	1,768	128
Foreign currency forward contracts | Other, net | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Net Income	(3,781)	478
Commodity forward contracts | Other, net | Not designated
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Net Income	$ (5,575)	$ 1,123

Acquisitions and Divestitures -

Acquisitions and Divestitures - Narrative (Details) € in Millions	Sep. 13, 2019EUR (€)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of businesses acquired	1
Other Acquisition
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase price	€ 30

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)segment	Mar. 31, 2019USD ($)
Segment Reporting [Abstract]
Number of reporting segments | segment	2
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	$ 774,269	$ 870,499
Operating income	58,599	142,596
Amortization of intangible assets	(33,092)	(36,143)
Interest expense, net	(39,403)	(39,253)
Other, net	(12,281)	3,189
Income before taxes	6,915	106,532
Performance Sensing
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	568,689	640,028
Sensing Solutions
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	205,580	230,471
Operating segments
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	774,269	870,499
Operating income	185,011	225,478
Operating segments | Performance Sensing
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	568,689	640,028
Operating income	129,062	150,509
Operating segments | Sensing Solutions
Reconciliation from Segment Totals to Consolidated [Abstract]
Net revenue	205,580	230,471
Operating income	55,949	74,969
Corporate and other
Reconciliation from Segment Totals to Consolidated [Abstract]
Operating income	(88,822)	(41,430)
Segment reconciling items
Reconciliation from Segment Totals to Consolidated [Abstract]
Amortization of intangible assets	(33,092)	(36,143)
Restructuring and other charges, net	$ (4,498)	$ (5,309)

Subsequent Events (Details)

Subsequent Events (Details) - Line of Credit - Revolving Credit Facility - Subsequent Event $ in Millions	Apr. 01, 2020USD ($)
Subsequent Event [Line Items]
Long-term line of credit	$ 400
Cash on hand	$ 1,200